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Abstract 
The author investigated the effects of O.OSmg ethyloestradiol and 0.25mg d-norgestrel on 
endrometrium. He established that this combination is capable of emergency contraception, because 
it prevents the implantation of the fertilized ovum. 
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Introduction 
With optimal administration of d-norgestrel no cells of chorial origin were 
detectable in the pre-menstruation histological samples. Moreover, no sign of 
secretion or predecidual reaction was seen (FARKAS et al., 1982). 
Serum progesteron levels measured on the 21. day of the cycle proved that in 
most cases the drug can have an ovulation-inhibitory effect even at optimal 
administration, therefore, the prevention of nidation was not possible (FARKAS et 
al., 1982). 
The drug can be taken as effective for post-coital contraception even at low 
dosage and in the case of multiplied intercourses (FARKAS and SAS, 1984). 
A sperm needs 90 seconds to get to the cervix, while the inhibition of the 
penetration of sperms develops after 3 hours of administration of the drug (KESERŰ 
and PARRADA, 1975). 
Frequent occurrance of extrauterine pregnancy indicated the tubamobility-
decreasing effect of the drug (FARKAS, 1994). 
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In order to reduce the side effects, we proposed to bring out a contraceptive 
drug with low estrogen content (FARKAS et al., 1981, FARKAS and SAS, 1984, 
FARKAS, 1978). 
In the course of contraception with Ovidon (0.05 mg ethyloestradiol and 0.25 
mg d-norgestrel) we observed a shortening of the proliferation period without 
presecretion period to occur (OUTLOOK..., 1966). 
Prolonged administration of Ovidon pills frequently led to functional infertility 
(GOLDZICHERT et al., 1964). 
The clinico-pharmacological studies carried out so far indicate that the active 
compounds of Ovidon can be used, in addition to the inhibition of ovulation, for 
the inhibition of nidation, as well (FARKAS, 1979, FARKAS et al., 1976). 
Yuzpe (FARKAS and KAJTAR, 1996) reported about the success of com-bined 
administration of de-norgestrel and ethyloestradiol. 
Material and methods 
Changes in the endometrium were analysed following administration of Ovidon 
pills (0.05 mg ethyloestradiol and 0.25 mg sd-norgestrel). Therefore, 15 patients 
underwent a stripe-curettage between the 16th and 25th day of the cycle. 
The small pieces of corpus mucosa obtained from the curettage were transferred 
immediately into 10% (v/v) neutral formaline. Duration of the fixation was usually 
20 to 24 hours. The fixed and cleaned samples were then embedded in paraffin and 
series of slices were produced from them. 
The series of slices are useful to detect changes in any histological sample, even 
if they are best visible at another cutting plane. 
After deparaffinization and dehydration, the samples were investigated by light 
microscopy after haematoxylin-eosin staining following a routine histological 
operation. The histological samples were compared with those obtained in the 
physiological and secretion period, as well as with histological alterations on the 
effects of high-dose drugs from our own earlier samples and from literature 
observations. 
Results 
In those cases where the cycle was built up by Ovidon administration (a 
relatively short duration of drug treatment) significant alterations were detected in 
the endometrium, as compared with that of normal cycle. 
Several glands were found to exhibit atrophy of differing extent. Some of them 
became narrow, others became large, sometimes they became microcystic and their 
lumen became empty. These are usually lined b y a single layer of cuboidal epi-
thelial cells. 
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These glands which are lined by different types of epithelia can be found next 
to each other quite often. In some glands even flattened, endothel-like epithelial 
lining can also be observed. 
In several cases small vacuoles are seen near the nuclei which contain glycogen 
by PAS staining. These vacuoles are very variable in location, they do not show 
the regularity which is detectable in the corresponding period of the normal cycle 
and only in several glands or gland epithelium. 
The presence of glycogen is anticipated mainly in those cases where the pro-
gesteron derivative is in excess. In no cases was glygogen detected in the lumen. In 
the second part of the cycle, no mitosis can be seen in the cells of gland epithe-
lium. 
The focal oedema of the stroma is well detectable. The oedematous, loose areas 
in the neighbourhood of densely packed regions are especially well visible (Fig. 
4/a). 
It is well seen that the ratio of glands to stroma is shifted in favour of the 
stroma. N o expressed predecidual transformation of the stroma cells was observed, 
indicating that the progestogene component of the drug was not dominant. 
Differentiation of stroma cells was not detectable following administration with 
Ovidon in these short administration periods. Predecidual transformation took 
place only in small areas, although these areas contain relatively large number of 
Figure 1/a. The surface of the endometrium is 
uneven. The stroma contains signs of focal 
oedemas and bleedings. The glands are tight, 
their epithelia are not secernating. 
Age: 24 years. Last normal menstruation: 
15 June. Duration of drug admi-nistration: 2 
years. Date of biopsy: 9 July (24Ul day) 
Quantity of drug administered during the 
cycle: 4.25 mg d-norgestrel and 0.085 mg 
ethyloestradiol. Obstetrical events: obstesy: 1, 
abortion: 0. Last obstetrical event: obstesy on 
15 May, 1981. 
F igure 1/b. Corpus mucosa polyposus. The stro-
ma is loosened, narrow inactive glands are vi-
sible in it, their number is reduced. Stroma 
cells are slightly swollen. 
Age: 24 years. Last normal menstruation: 
15 June. Duration of drug administration: 2 
years. Date of biopsy: 9 July (24111 day) 
Quantity of drug administered during the 
cycle: 4.25 mg d-norgestrel and 0.085 mg 
ethyloestradiol. Obstetrical events: obstesy: 1, 
abortion: 0. Last obstetrical event: obstesy on 
15 May 1981. 
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endometrial granulocytes. In the other areas of the stroma, however, no sign of 
cellular differentiation can be seen. 
The reticulum fibre network of the stroma is variable. It is well developed in 
the densely packed areas, whereas it is underdeveloped in the loose regions. 
The spiral arteries are usually underdeveloped: only small, linear capillaries can 
be seen, with dilatated thin-walled arteries in other areas (Figs. 4/b and 4/c). 
Long-term treatment (up to several years) resulted in a surprising histological 
pattern. Abortive secretion was seen only occasionally in the glandular epithelium 
(Figs. 1/a and 1/b). 
The number of glands is decreased from cycle to cycle, finally they disappear 
or only their residues can be seen. These residues are glands with endothel-like 
epithelium lining which can be easily mistaken for the capillaries (Figs. 2/a, 2/b, 
2/c and 2/d). 
The stroma does not exhibit atrophy in all cases. Decrease in the number of 
stroma cells and their replacement by collagen was detectable only focally (Figs. 
3/a and 3/b). 
Figure 2/a. The surface of the mucous mem-
brane segment is uneven, the number of 
glands is reduced, their lumen is narrow, they 
are lined by one-nucleus non-secernating epi-
thelium. The stroma is in excess, the cells are 
slightly swollen, its structure is loose. 1 or 2 
thick arteries can be seen instead of spiral ar-
teries. 
Age: 33 years. Last normal menstruation: 
16 June. Duration of drug administration: 2 
years. Date of biopsy: 12 July (25lh day). 
Quantity of drug administered during the 
cycle: 4.5 mg d-norgestrel and 0.090 mg ethy-
loestradiol. Obstetrical events: obstesy: 3, ab-
ortion: 1. Last obstetrical event: obstesy on 
30 November 1981. 
Figure 2/b. Only tight inactive glands cen be 
seen. The stroma is in excess. 
Age: 33 years. Last normal menstruation: 
16 June. Duration of drug administration: 2 
years. Date of biopsy: 12 July (25 J| day). 
Quantity of drug administered during the 
cycle: 4.5 mg d-norgestrel and 0.090 mg ethv-
loestradiol. Obstetrical events: obstesy: 3, ab-
ortion: 1. Last obstetrical event: obstesy on 
30 November, 1981. 
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Figure 2/c. Only several glands can be seen 
which are not secernating and are lined by 
(inactive epithelium. The stroma cells are 
slightly swollen, with several thin-walled 
capillaries between them. N o spinal arteries 
are developed. 
Age: 33 years. Last normal menstruation: 
16 June. Duration of drug administration: 2 
years. Date of biopsy: 12 July (25th day). 
Quantity of drug administered during the 
cycle: 4.5 mg d-norgestrel and 0.090 mg 
ethyloestradiol. Obstetrical events: obstesy: 3, 
abortion: 1. Last obstetrical event: obstesy on 
F igure 3/a. The number of corpus glands is 
small, or they can be observed focally in 
smaller or bigger groups. The glandular epi-
thelium is inactiove. The stroma predomi-
nates. The cells are slightly swollen, or the 
structure is loosened. 
Age: 33 years. Last normal menstruation: 
15 June. Duration of drug administration: 7 
years. Date of biopsy: 6 July (22lh day). 
Quantity of drug administered during the 
cycle: 3.75 mg d-norgestrel and 0.085 mg 
ethyloestradiol. Obstetrical events: obstesy: 2, 
abortion: 2. Last obstetrical event: obstesy on 
8 December, 1977. 
Figure 2/d. Tight and wide-lumen glands are al-
so detectable. The epithelium is not secerna-
ting. The stroma is made up of moderately 
swollen cells. The number of endometrial 
granulocytes is small. Spiral arteries are not 
developed. 
Age: 33 years. Last normal menstruation: 
16 June. Duration of drug administration: 2 
years. Date of biopsy: 12 July (25lh day). 
Quantity of drug administered during the 
cycle: 4.5 mg d-norgestrel and 0.090 mg ethy-
loestradiol. Obstetrical events: obstesy: 3, ab-
ortion: 1. Last obscetrical ercnt : obstesy on 
Figure 3/b. In the predominating stroma only 
very few glands can be seen which are lined 
by low cylindrical or cubic epithelium. The 
epithelium is inactive. Several wide-lumen ar-
teries can be seen. 
Age: 33 years. Last normal menstruation: 
15 June. Duration of drug administration: 7 
years. Date of biopsy: 6 July (22lh day). 
Quantity of drug administered during the 
cycle: 3.75 mg d-norgestrel and 0.085 mg 
ethyloestradiol. Obstetrical events: obstesy: 2, 
abortion: 2. Last obstetrical event: obstesy on 
8 December, 1977. 
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We could not detect any sign of 
hyperplasia, that is why no atypic glandu 
developed. 
Figure 4/a. The surface of the mucous mem-
brane is slightly uneven. T h e number of 
glands is reduced, in some parts secretion of 
variable extent, mainly abortive, can be seen. 
In other areas the glandular epithelium is not 
secernating. 
Age: 28 years. Last normal menstruation: 
24 June. Duration of drug administration: 1 
year. Date of biopsy: 10 July (16 ,h day). 
Quantity of drug administered during the 
cycle: 2.25 mg d-norgestrel and 0.35 mg ethv-
loestradiol. Obstetrical events: obstesy: 2, ab-
ortion: 1. Last obstetrical event: obstesy on 
16 June, 1980. 
glandularcystic hyperplasia or stroma 
ar epithelium or atypic stroma cells were 
Figure 4/b. Similar to the picture of Fig. 4/B. In 
the stroma signs signs of focal bleedings and 
oedema can be seen. T h e loosening of the 
stroma is more expressed. 
Age: 28 years. Last normal menstruation: 
24 June. Duration of drug administration: 1 
year. Date of biopsy: 10 July (16lh day). 
Quantity of drug administered during the 
cycle: 2.25 mg d-norgestrel and 0.35 mgethv-
loestradiol. Obstetrical events: obstesy: 2, ab-
ortion: 0. Last obstetrical event: obstesy on 
16 June, 1980. 
Figure 4/c. The structure of the stroma is 
loose, in it rcduced number of inactive cor-
pus-glands and thin-walled wide arteries can 
be occasionally seen. N o sign of any secre-
tion. 
Age: 28 years. Last normal menstruation: 
24 June. Duration of drug administration: 1 
year. Date of biopsy: 10 July (16lh day). 
Quantity of drug administered during the 
cycle: 2.25 mg d-norgestrel and 0.35 mg ethy-
loestradiol. Obstetrical events: obstesy: 2, ab-
ortion: 1. Last obstetrical event: obstesy on 
16 June, 1980. 
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Discussion 
After the treatment we observed a gestagene-induced suppression phenomenon, 
characterized by the shortening of the proliferation period and by a premature 
reduced secretion activity (FARKAS, 1979, FARKAS et al., 1976, OUTLOOK..., 1966). 
T h e glycogen present in the glandular epithelium was abundant in those cases 
where the gestagene component was dominant in the applied drug (SLEDEL and 
HEINEN, 1965). 
T h e majority of the glands became dormant after the 15th day of treatmen. W e 
could not detect any unequivocal sign of predecidual or decidual stroma cell 
transformation, indicating the harmonized gestagenous action of the drug 
( O U T L O O K . . . , 1 9 6 6 ) . 
Dominant gestagenous effect results in predecidual or decidual transformation 
in an early stage ascompared with the normal cycle, usually between the 15th and 
20th days of the created cycle (RYAN et al., 1964, STARUP, 1967, TAYLOR, 1961). 
The spiral arteries of the stroma did not develop at all, or if they did, they 
became small, linear capillaries, sometimes dilatated thin-walled arteries (OBER et 
al., 1964, OBER, 1966). 
Long-term administration resulted in a reduction of the number of glands. 
Abortive secretion was detectable only occasionally, it was not present in many 
cases (KESERŰ and PARRADA, 1975, RYAN et al., 1964). 
Such a histological pattern is difficult to distinguish from physiological atrophy, 
the atrophy present in the endometrium of castrated women ( C H A R L E S , 1 9 6 4 , 
S H E F F I E L D e t a l . , 1 9 6 9 1 ) . 
During the 9 days until the 16th day of the cycle, altogether 2.25 mg d-
norgestrel and 0.35 mg ethyloestradiol were taken up by the patients, which 
prevented the advantegous physiological changes necessary for the implantation of 
the morula. 
In the early 1980s more than 200 under-18 curettage were performed at the 
Department of Gynaecology. In 5 month, 11 out of 49 under-18 curettages were 
necessary because the women had been taking Postinor as a contraceptive drug; 30 
out of them employed interrupted intercourse, while 8 had not used any means of 
contraception. 
The 11 curettages mentioned above were carried out on under-16 patients. It 
can be concluded that administration of Postinor requires rigorous attention as 
unattentive administration leads to unwanted pregnancy. 
Hungarian bibliographical data vary considerably in terms of reliability o f the 
drug, too. T h e value of the PEARL-index changes between 0 and 12.8 with similar 
number of patients and cycles. This high variability is not seen in the international 
literature (variability is between 0 and 5.8), although the active content of the drug 
is lower there than that of Postinor. 
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The total dose recommended by YUZPE (YUZPE and LANCEE, 1977) was 200 
ng ethyloestradiol and 2 mg dl-norgestrel. 70 .4% of the women were treated within 
24 hours of the intercourse, 22 .7% of them between 24 and 48 hours, and 6 % of 
them were treated between 48 and 72 hours after the intercourse. O f the 464 
women having normal cycle the sexual intercourse was in the middle of the cycle. 
Only 1 pregnancy happened, caused by a mistake of the method, as compared with 
the minimally expectable 12-30 pregnancies. According to the cumulative rale, 
48% of the patients had menstrual bleeding within the first 6 days of the 
treatment, 71% of them within the first 9 days, 95% of them within the first 15 
days and the rest of them within the first 25 days. 
In the combined treatment (50 mg ethyloestradiol and 0.25 mg levonorgestrel, 
also called as Yuzpe-method) the women take 2 pills within the first 72 hours after 
the intercourse, followed by 2 more pills during the next 12 hours. 
The efficiency of the method is highlighted by the fact that following 1 
contraception-devoid intercourse only 2 % of the women following combined 
treatment got pregnant, as compared with the 8 % of pregnancy of women without 
using urgency contraceptive pills (OUTLOOK, 1966). This means that the combined 
treatment reduces the chance of pregnancy by 75%. 
During 3 days of administration with Fertilin, altogether 1 mg d-norgestrel and 
0.20 mg ethyloestradiol were taken up by the patients. Supposedly the active 
content in this short period can prevent the physiological changes that are 
necessary to take place in the stromal and glandular region of the mucous 
membrane necessary for the implantation of the fertilized ovum. The drug-induced 
peripheral change taking place during 72 hours does not provide an optimal milieu 
for the nourishment of the morula, which then dies in a short time. T h e drug, 
therefore, can prevent pregnancy by inhibiting implantation. 
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